1. Lovastatin causes FaDu hypopharyngeal carcinoma cell death via AMPK-p63-survivin signaling cascade
    Chia-Sheng Yen et al, 2016, Sci Rep CrossRef
  2. Is There a Role for Statins in Palliative Care for Patients Suffering from Hepatocellular Carcinoma?
    Linda Björkhem-Bergman, 2015, J Palliat Care CrossRef
  3. Anti-inflammatory Effects of Atorvastatin by Suppressing TRAF3IP2 and IL-17RA in Human Glioblastoma Spheroids Cultured in a Three-dimensional Model: Possible Relevance to Glioblastoma Treatment
    Neda Bayat et al, 2018, Mol Neurobiol CrossRef
  4. Effects of Aspirin, Nonsteroidal Anti-inflammatory Drugs, Statin and COX2 Inhibitor on the Developments of Urological Malignancies: A Population-Based Study with 10-Year Follow-up Data in Korea
    Minyong Kang et al, 2017, Cancer Res Treat CrossRef
  5. Less cholesterol means better tumor killing for cytotoxic T9 cells.
    Brad Griesenauer et al, 2018, J Exp Med CrossRef
  6. Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target
    Ramona Schulz-Heddergott et al, 2018, Cancers CrossRef
  7. The poor design of clinical trials of statins in oncology may explain their failure – lessons for drug repurposing
    Marwan I. Abdullah et al, 2018, Cancer Treatment Reviews CrossRef
  8. Combination statin and chemotherapy inhibits proliferation and cytotoxicity of an aggressive natural killer cell leukemia
    Austin B. Henslee et al, 2018, Biomark Res CrossRef
  9. Loading lovastatin into camptothecin-floxuridine conjugate nanocapsules for enhancing anti-metastatic efficacy of cocktail chemotherapy on triple-negative breast cancer
    Nisi Zhang et al, 2018, ACS Appl. Mater. Interfaces CrossRef
  10. Hybrid nanocarrier system for guiding and augmenting simvastatin cytotoxic activity against prostate cancer
    Mohammed Sedki et al, 2018, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
  11. Statin use and mortality among endometrial cancer patients: a Danish nationwide cohort study
    Cecilie D. Sperling et al, 2018, Int. J. Cancer CrossRef
  12. Boosting Immunity by Targeting Post-translational Prenylation of Small GTPases
    Caroline Robert et al, 2018, Cell CrossRef
  13. Statins: a new approach to combat temozolomide chemoresistance in glioblastoma
    Shahla Shojaei et al, 2018, J Investig Med CrossRef
  14. Statin therapy in the treatment of active cancer: A systematic review and meta-analysis of randomized controlled trials
    Mohammed A. M. Farooqi et al, 2018, PLoS ONE CrossRef
  15. Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults – A systematic review and meta-analysis
    B. Pertzov et al, 2018, Clinical Microbiology and Infection CrossRef
  16. Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin resistance in breast cancer cells
    Andy Göbel et al, 2019, Cell Death Dis CrossRef
  17. Chitosan-Coated Nanoparticles: Effect of Chitosan Molecular Weight on Nasal Transmucosal Delivery
    Franciele Bruinsmann et al, 2019, Pharmaceutics CrossRef
  18. Biocatalyzed Synthesis of Statins: A Sustainable Strategy for the Preparation of Valuable Drugs
    Pilar Hoyos et al, 2019, Catalysts CrossRef
  19. DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway.
    Alejandro Parrales et al, 2016, Nat Cell Biol CrossRef
  20. Ferroptosis suppressed the growth of melanoma that may be related to DNA damage
    Zhenying Wang et al, 2019, Dermatologic Therapy CrossRef
  21. An overview of the bioactivity of monacolin K / lovastatin
    Zixiao Xiong et al, 2019, Food and Chemical Toxicology CrossRef
  22. P53- and mevalonate pathway–driven malignancies require Arf6 for metastasis and drug resistance
    Ari Hashimoto et al, 2016, J. Cell Biol. CrossRef
  23. A New Method for Ethical and Efficient Evidence Generation for Off-Label Medication Use in Oncology (A Case Study in Glioblastoma)
    Samir Agrawal et al, 2019, Front. Pharmacol. CrossRef
  24. Screening a library of approved drugs reveals that prednisolone synergizes with pitavastatin to induce ovarian cancer cell death
    Marwan Ibrahim Abdullah et al, 2019, Sci Rep CrossRef
  25. The association between statin use and survival of esophageal cancer patients
    Han-Yu Deng et al, 2019, Medicine CrossRef
  26. Inhibition of mutant Kras and p53‐driven pancreatic carcinogenesis by atorvastatin: Mainly via targeting of the farnesylated DNAJA1 in chaperoning mutant p53
    Dandan Xu et al, 2019, Mol Carcinog CrossRef
  27. Ouabain induces apoptotic cell death in human prostate DU 145 cancer cells through DNA damage and TRAIL pathways.
    Yi-Ming Chang et al, 2019, Environ Toxicol CrossRef
  28. The Hippo signal transduction pathway in soft tissue sarcomas
    Abdalla D. Mohamed et al, 2015, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  29. Exploitation of pleiotropic actions of statins by using tumour-targeted delivery systems
    Emilia Licarete et al, 2015, Journal of Microencapsulation CrossRef
  30. Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling Pathways
    Svenja Nölting et al, 2015, PLoS ONE CrossRef
  31. Statins: A Conceivable Remedial Role for the Regulation of Cancer Progression
    Gajanan V. Sherbet, 2019, CCTR CrossRef
  32. Effect of Statins on the Nanomechanical Properties of Supported Lipid Bilayers
    Lorena Redondo-Morata et al, 2016, Biophysical Journal CrossRef
  33. Statin use and risk of endometrial cancer: a nationwide registry-based case-control study
    Cecilie D. Sperling et al, 2017, Acta Obstet Gynecol Scand CrossRef
  34. Cratoxy formosum leaf extract inhibits proliferation and migration of human breast cancer MCF-7 cells
    Benjaporn Buranrat et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  35. Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanisms
    Yong Zhang et al, 2017, Sci. China Life Sci. CrossRef
  36. Statins: Complex outcomes but increasingly helpful treatment options for patients
    Niloufar Mohammadkhani et al, 2019, European Journal of Pharmacology CrossRef
  37. Dietary geranylgeraniol can limit the activity of pitavastatin as a potential treatment for drug-resistant ovarian cancer
    Elizabeth de Wolf et al, 2017, Sci Rep CrossRef
  38. Postdiagnosis Statin Use and Mortality in Danish Patients With Prostate Cancer
    Signe Benzon Larsen et al, 2017, JCO CrossRef
  39. Inhibition of the mevalonate pathway augments the activity of pitavastatin against ovarian cancer cells
    Marwan Ibrahim Abdullah et al, 2017, Sci Rep CrossRef
  40. The ABC subfamily A transporters: multifaceted players with incipient potentialities in cancer
    Michela Pasello et al, 2019, Seminars in Cancer Biology CrossRef
  41. Validation of human sterol 14α-demethylase (CYP51) druggability: structure-guided design, synthesis and evaluation of stoichiometric, functionally irreversible inhibitors
    Laura Friggeri et al, 2019, J. Med. Chem. CrossRef
  42. Drug Repurposing in the Development of Anticancer Agents
    Sureyya Olgen et al, 2019, CMC CrossRef
  43. Selected pharmacotherapy agents as antiproliferative and anti‐inflammatory compounds
    Mthanna AlKhalil et al, 2020, Drug Dev Res CrossRef
  44. Repurposing drugs for the treatment of glioma
    Chengming Xu et al, 2019, Glioma CrossRef
  45. Transcriptional Coactivator TAZ Negatively Regulates Tumor Suppressor p53 Activity and Cellular Senescence
    Chiharu Miyajima et al, 2020, Cells CrossRef
  46. Cholesterol and beyond - The role of the mevalonate pathway in cancer biology
    Andy Göbel et al, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  47. Repurposing of drugs approved for cardiovascular diseases: opportunity or mirage?
    Paolo Gelosa et al, 2020, Biochemical Pharmacology CrossRef
  48. A remarkable in vitro cytotoxic, cell cycle arresting and proapoptotic characteristics of low-dose mixed micellar simvastatin combined with alendronate sodium
    Sandip A. Bandgar et al, 2020, Drug Deliv. and Transl. Res. CrossRef
  49. Statin use and the prognosis of patients with hepatocellular carcinoma: a meta-analysis
    Xiaofei Li et al, 2020 CrossRef
  50. Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis
    Xiaofei Li et al, 2020, BMC Gastroenterol CrossRef
  51. Common medications and survival in women with ovarian cancer: A systematic review and meta-analysis.
    Azam Majidi et al, 2020, Gynecol Oncol CrossRef
  52. Lovastatin induced Kruppel like factor 2 (KLF2), Kruppel like factor 6 (KLF6) and Ras homolog family member B (RHOB) genes and preferentially led to viability reduction of Cisplatin-resistant cells
    Chiho Koi et al, 2017, Oncotarget CrossRef
  53. Synergistic Anticancer Effects of Gemcitabine with Pitavastatin on Pancreatic Cancer Cell Line MIA PaCa-2 in vitro and in vivo


    Ya-Hui Chen et al, 2020, CMAR CrossRef
  54. Metabolic networks in ferroptosis (Review)
    Shihui Hao et al, 2018, Oncol Lett CrossRef
  55. Atorvastatin in combination with radiotherapy and temozolomide for glioblastoma: a prospective phase II study
    Abdullah K. Altwairgi et al, 2020, Invest New Drugs CrossRef
  56. null
    Süreyya Ölgen, 2020 CrossRef
  57. Pleiotropic effects of statins: A focus on cancer
    Mazaher Ahmadi et al, 2020, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
  58. Lipid-lowering medication use and cancer-specific survival among endometrial or lung cancer patients: an Australian nationwide cohort study
    Jia-Li Feng et al, 2020, Eur J Clin Pharmacol CrossRef
  59. Association Between Statins and Cancer Incidence in Diabetes: a Cohort Study of Japanese Patients with Type 2 Diabetes
    Sadanori Okada et al, 2020, J GEN INTERN MED CrossRef
  60. Association Between Statin Use and Prognosis of Breast Cancer: A Meta-Analysis of Cohort Studies
    Hui Lv et al, 2020, Front. Oncol. CrossRef
  61. Simvastatin Induces Unfolded Protein Response and Enhances Temozolomide-Induced Cell Death in Glioblastoma Cells
    Sanaz Dastghaib et al, 2020, Cells CrossRef
  62. Development of Cancer in Patients With Heart Failure: How Systemic Inflammation Can Lay the Groundwork
    Simonetta Ausoni et al, 2020, Front. Cardiovasc. Med. CrossRef
  63. Targeting Rac and Cdc42 GTPases in Cancer
    María del Mar Maldonado et al, 2018, Cancer Res CrossRef
  64. The antagonistic atorvastatin-glibenclamide interactions suppressed the atorvastatin-induced Bax/cytochrome c/ p53 mRNA expressions and increased rho a mRNA expression in B16f10 melanoma cell culture
    Maryam Malek et al, 2021, Gene Reports CrossRef
  65. Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy
    Isabella Giacomini et al, 2021, Front. Oncol. CrossRef
  66. Cytotoxic activity of cholesterol oxidase produced by Streptomyces sp. AKHSS against cancerous cell lines: mechanism of action in HeLa cells
    Kavitha Alapati et al, 2021, World J Microbiol Biotechnol CrossRef
  67. Effects of Statins on the Incidence and Mortality of Sepsis in Patients with New Cancer Diagnosis
    Andry Van de Louw et al, 2021, JCM CrossRef
  68. Effects of Sublethal Concentration of Metamifop on Hepatic Lipid Metabolism in Adult Zebrafish (Danio rerio)
    Feng Zhao et al, 2021, Aquatic Toxicology CrossRef
  69. Fursultiamine Prevents Drug-Induced Ototoxicity by Reducing Accumulation of Reactive Oxygen Species in Mouse Cochlea
    Ye-Ri Kim et al, 2021, Antioxidants CrossRef
  70. Combination of Simvastatin and FAC Improves Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
    Erwin Danil Yulian et al, 2021, Cancer Res Treat CrossRef
  71. Natural Compounds as Target Biomolecules in Cellular Adhesion and Migration: From Biomolecular Stimulation to Label-Free Discovery and Bioactivity-Based Isolation
    Beatrix Péter et al, 2021, Biomedicines CrossRef
  72. Crosstalk between Statins and Cancer Prevention and Therapy: An Update
    Beniamin Oskar Grabarek et al, 2021, Pharmaceuticals CrossRef
  73. Dynamics of Endocytosis and Degradation of Antibody-Drug Conjugate T-DM1 in HER2 Positive Cancer Cells
    Keying Liang et al, 2021, DDDT CrossRef
  74. Lipid-lowering drug adherence and combination therapy effects on gastrointestinal cancer in patients with dyslipidemia without diabetes: a retrospective cohort study in South Korea
    Kyu-Tae Han et al, 2022, BMC Cancer CrossRef
  75. Identification of foods that affect the anti‑cancer activity of pitavastatin in cells
    Mohammed Jawad et al, 2022, Oncol Lett CrossRef
  76. Nose-to-brain delivery of simvastatin mediated by chitosan-coated lipid-core nanocapsules allows for the treatment of glioblastoma in vivo
    Franciele Aline Bruinsmann et al, 2022, International Journal of Pharmaceutics CrossRef
  77. Simvastatin Inhibits Tumor Growth and Migration by Mediating Caspase-1–Dependent Pyroptosis in Glioblastoma Multiforme
    Shulong Yang et al, 2022, World Neurosurgery CrossRef
  78. Metabolic Syndrome Is Associated with Impaired Survival after Surgery for Pancreatic Neuroendocrine Tumors
    Fayez Awwad et al, 2022, Neuroendocrinology CrossRef
  79. Associations between statins and adverse events in secondary prevention of cardiovascular disease: Pairwise, network, and dose-response meta-analyses of 47 randomized controlled trials
    Xinyi Wang et al, 2022, Front. Cardiovasc. Med. CrossRef
  80. A method of isolating and analysing drugs from cancer cells for preclinical research
    W. Placha et al, 2022, Journal of Chromatography A CrossRef
  81. ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis
    Michela Pasello et al, 2022, Cell Oncol. CrossRef
  82. null
    José M. García-Castellano et al, 2022 CrossRef
  83. Advances in ovarian cancer treatment using a combination of statins with other drugs
    Lei Xia et al, 2023, Front. Pharmacol. CrossRef
  84. The roles of ATP‐binding cassette transporter A1 and its substrate cholesterol in head and neck cancers
    Fatma Sanli et al, 2023, Cell Biology International CrossRef
  85. Statin Use During Concurrent Chemoradiotherapy With Improved Survival Outcomes in Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Nationwide Cohort Study
    Wan-Ming Chen et al, 2023, Journal of Thoracic Oncology CrossRef
  86. Some pleiotropic effects of statins on hepatocellular carcinoma cells: Comparative study on atorvastatin, rosuvastatin and simvastatin
    Esmeralda Dautović et al, 2023, Advances in Medical Sciences CrossRef
  87. Don’t Judge a Book by Its Cover: The Role of Statins in Liver Cancer
    Natalia Piekuś-Słomka et al, 2023, Cancers CrossRef
  88. Pitavastatin induces caspase‐mediated apoptotic death through oxidative stress and DNA damage in combined with cisplatin in human cervical cancer cell line
    Aysun Ökçesiz Hacıseyitoğlu et al, 2023, J of Applied Toxicology CrossRef
  89. Simvastatin activates the spindle assembly checkpoint and causes abnormal cell division by modifying small GTPases
    Junna Tanaka et al, 2024, Cellular Signalling CrossRef
  90. Statins as anti‐tumor agents: A paradigm for repurposed drugs
    Sneha Tripathi et al, 2024, Cancer Reports CrossRef
  91. Red Blood Cell-Hitchhiking Delivery of Simvastatin to Relieve Acute Respiratory Distress Syndrome
    Mengjuan Sun et al, 2024, IJN CrossRef